Expression Level and Clinical Significance of NKILA in Human Cancers: A Systematic Review and Meta-Analysis

Table 2

Meta-analysis results for the association of overexpressed NKILA with clinicopathological parameters.

Clinicopathological parameters	Studies ()	Numbers of patients	OR (95% CI)	value	Heterogeneity
						pH	Model
Clinical stage (III/IV vs. I/II)	6	652	0.313 (0.225, 0.434)	≤0.001	0.00%	>0.05	Fixed effects
Histological grade (poorly/others vs. well/moderately)	5	658	0.661 (0.478, 0.914)	≤0.05	17.30%	>0.05	Fixed effects
Lymph node metastasis (+ vs. -)	3	231	0.253 (0.144, 0.444)	≤0.001	0.00%	>0.05	Fixed effects
Tumor invasion depth (T3/T4 vs. T1/T2)	5	664	0.326 (0.234, 0.454)	≤0.001	0.00%	>0.05	Fixed effects